Indication-Based Formulary Design Beginning in Contract Year (CY) 2020
Guidance for providing Part D plans with new tools that have been successful in the private sector in reducing drug costs and is an important step in putting patients’ needs first and delivering on this important objective in Contract Year 2020.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 29, 2018
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.